Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials-Reference-Cited by-同舟云学术

Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials

Published:2022-10 Issue:10 Volume:4 Page:e679-e687
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Hoffmann-Vold Anna-Maria,Volkmann Elizabeth R,Allanore Yannick,Assassi Shervin,de Vries-Bouwstra Jeska K,Smith Vanessa,Tschoepe Inga,Loaiza Lazaro,Kanakapura Madhu,Distler Oliver

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference33 articles.

1. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database;Hoffmann-Vold;Ann Rheum Dis,2021

2. The incidence, risk factors, and mortality of clinical and subclinical rheumatoid arthritis-associated interstitial lung disease: a population-based cohort;Samhouri;Arthritis Care Res (Hoboken),2022

3. High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis;Hayashi;J Rheumatol,2008

4. Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study;Reiseter;Rheumatology (Oxford),2018

5. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics—a large multicentre UK study;Kelly;Rheumatology (Oxford),2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scattered pustular lesions 10 days after Shingrix vaccination in systemic sclerosis patient after successful autologous non-myeloablative haemopoietic stem-cell transplantation;BMJ Case Reports;2024-07

2. Geschlechtersensible Aspekte in der Rheumatologie;Zeitschrift für Rheumatologie;2024-06-13

3. Interstitial Lung Disease Associated with Systemic Sclerosis;Seminars in Respiratory and Critical Care Medicine;2024-05-07

4. Key learnings from the INBUILD trial in patients with progressive pulmonary fibrosis;Therapeutic Advances in Respiratory Disease;2024-01

5. Gastrointestinal and Skin Safety Evaluation of Pirfenidone Versus Nintedanib: An Analysis of Real-World Pharmacovigilance and Randomized Controlled Trials;2024